South Korea Asserting its Contribution in the Asia Pacific Biotech Market

The South Korean biotech industry is expected to grow at a CAGR of around 35% during 2010-2013, thereby contributing majorly to the Asia Pacific biotech market, says RNCOS in its latest research.

Noida, India (prHWY.com) June 28, 2011 - South Korea has been one of the leaders in the world of technology, and has also come to lead the biotechnology market as well. The seed of biotech industry were sown in 1990s in the country, and has come a long way since then with the help of undying government support and exponentially rising investments. Additionally, the South Korean biotech industry has thrived due to the high levels of intellect, potential for research & development, and a vast population to cater to. Backed by all these factors, the South Korean biotech market is expected to grow at a stupendous CAGR of 35% during 2010-2013, according to our new research report "Asia Pacific Biotechnology Market (2008-2012)".

Delving further into the industry led our team of experts to deduce that the South Korean biotech companies excel particularly in the areas of genetic materials, genetic therapy, DNA chips, and genetically modified organisms. Coincidentally, these are the areas of research, which are dominating the global biotech scene and will help the local industry to grow to new levels internationally. Moreover, it was found that, the areas of biomedicines and biofood occupy the largest shares in the South Korean biotech market.

Besides South Korea, our report provides detail profiling of biotechnology markets of the fast developing countries in the APAC region, such as India, Japan, China, Malaysia, Singapore, Taiwan, Australia, and New Zealand. The main reason for the progress of the biotech industry in these countries has been the support provided by the government. To enumerate the same, a detail description of the government initiatives has been provided for each country covered in the report.

Our report "Asia Pacific Biotechnology Market (2008-2012)", provides thorough analysis of the various segments of the biotech industry at the regional and country level, along with descriptions regarding investment opportunities. The report has thoroughly examined current market trends, industrial developments, and competitive analysis to help clients understand the market structure and its progress in coming years. Due consideration has been given to the possible after effects of recession on the industry. It will help clients to have a proper insight of the current and future outlook of the Indian biotech market.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM138.htm

Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm

About RNCOS:

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: biosimilars

Categories: Business

Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code